nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A4—Temozolomide—melanoma	0.154	0.325	CbGbCtD
Oxybutynin—CYP2D6—Vemurafenib—melanoma	0.133	0.28	CbGbCtD
Oxybutynin—CYP3A4—Vemurafenib—melanoma	0.0844	0.178	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—melanoma	0.0743	0.157	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—melanoma	0.029	0.0611	CbGbCtD
Oxybutynin—Hexylcaine—SCN10A—melanoma	0.00411	1	CrCbGaD
Oxybutynin—Infestation NOS—Temozolomide—melanoma	0.00119	0.00333	CcSEcCtD
Oxybutynin—Infestation—Temozolomide—melanoma	0.00119	0.00333	CcSEcCtD
Oxybutynin—Depression—Temozolomide—melanoma	0.00119	0.00332	CcSEcCtD
Oxybutynin—Flushing—Bleomycin—melanoma	0.00118	0.00329	CcSEcCtD
Oxybutynin—Pharyngitis—Dactinomycin—melanoma	0.00118	0.00328	CcSEcCtD
Oxybutynin—Stomatitis—Temozolomide—melanoma	0.00116	0.00325	CcSEcCtD
Oxybutynin—Urinary tract infection—Temozolomide—melanoma	0.00116	0.00324	CcSEcCtD
Oxybutynin—Sinusitis—Temozolomide—melanoma	0.00112	0.00313	CcSEcCtD
Oxybutynin—Erythema—Bleomycin—melanoma	0.00111	0.00309	CcSEcCtD
Oxybutynin—Hallucination—Carmustine—melanoma	0.0011	0.00308	CcSEcCtD
Oxybutynin—Hypoaesthesia—Carmustine—melanoma	0.0011	0.00308	CcSEcCtD
Oxybutynin—Hot flush—Docetaxel—melanoma	0.0011	0.00307	CcSEcCtD
Oxybutynin—Flushing—Dactinomycin—melanoma	0.0011	0.00307	CcSEcCtD
Oxybutynin—Hypersensitivity—Vemurafenib—melanoma	0.0011	0.00306	CcSEcCtD
Oxybutynin—Oedema peripheral—Carmustine—melanoma	0.00109	0.00305	CcSEcCtD
Oxybutynin—Menopausal symptoms—Docetaxel—melanoma	0.00109	0.00305	CcSEcCtD
Oxybutynin—Connective tissue disorder—Carmustine—melanoma	0.00109	0.00304	CcSEcCtD
Oxybutynin—Dermatitis bullous—Docetaxel—melanoma	0.00108	0.00301	CcSEcCtD
Oxybutynin—Asthenia—Vemurafenib—melanoma	0.00107	0.00298	CcSEcCtD
Oxybutynin—Visual impairment—Carmustine—melanoma	0.00107	0.00298	CcSEcCtD
Oxybutynin—Hypoaesthesia—Temozolomide—melanoma	0.00107	0.00298	CcSEcCtD
Oxybutynin—Hallucination—Temozolomide—melanoma	0.00107	0.00298	CcSEcCtD
Oxybutynin—Pharyngitis—Temozolomide—melanoma	0.00106	0.00297	CcSEcCtD
Oxybutynin—Urinary tract disorder—Temozolomide—melanoma	0.00106	0.00295	CcSEcCtD
Oxybutynin—Oedema peripheral—Temozolomide—melanoma	0.00106	0.00295	CcSEcCtD
Oxybutynin—Pruritus—Vemurafenib—melanoma	0.00105	0.00294	CcSEcCtD
Oxybutynin—Connective tissue disorder—Temozolomide—melanoma	0.00105	0.00294	CcSEcCtD
Oxybutynin—Urethral disorder—Temozolomide—melanoma	0.00105	0.00293	CcSEcCtD
Oxybutynin—Eye disorder—Carmustine—melanoma	0.00104	0.00289	CcSEcCtD
Oxybutynin—Visual impairment—Temozolomide—melanoma	0.00103	0.00288	CcSEcCtD
Oxybutynin—Erythema—Dactinomycin—melanoma	0.00103	0.00288	CcSEcCtD
Oxybutynin—Pain in extremity—Docetaxel—melanoma	0.00103	0.00288	CcSEcCtD
Oxybutynin—Flushing—Carmustine—melanoma	0.00103	0.00287	CcSEcCtD
Oxybutynin—Ill-defined disorder—Bleomycin—melanoma	0.00103	0.00286	CcSEcCtD
Oxybutynin—Diarrhoea—Vemurafenib—melanoma	0.00102	0.00285	CcSEcCtD
Oxybutynin—Migraine—Docetaxel—melanoma	0.00101	0.00283	CcSEcCtD
Oxybutynin—Eye disorder—Temozolomide—melanoma	0.001	0.0028	CcSEcCtD
Oxybutynin—Tinnitus—Temozolomide—melanoma	0.000999	0.00279	CcSEcCtD
Oxybutynin—Malaise—Bleomycin—melanoma	0.000997	0.00278	CcSEcCtD
Oxybutynin—Flushing—Temozolomide—melanoma	0.000994	0.00278	CcSEcCtD
Oxybutynin—Cardiac disorder—Temozolomide—melanoma	0.000994	0.00278	CcSEcCtD
Oxybutynin—Arrhythmia—Carmustine—melanoma	0.00099	0.00277	CcSEcCtD
Oxybutynin—Dizziness—Vemurafenib—melanoma	0.000985	0.00275	CcSEcCtD
Oxybutynin—Angiopathy—Temozolomide—melanoma	0.000972	0.00271	CcSEcCtD
Oxybutynin—Mental disorder—Carmustine—melanoma	0.000971	0.00271	CcSEcCtD
Oxybutynin—Mediastinal disorder—Temozolomide—melanoma	0.000966	0.0027	CcSEcCtD
Oxybutynin—Erythema—Carmustine—melanoma	0.000965	0.00269	CcSEcCtD
Oxybutynin—Malnutrition—Carmustine—melanoma	0.000965	0.00269	CcSEcCtD
Oxybutynin—Cough—Bleomycin—melanoma	0.000965	0.00269	CcSEcCtD
Oxybutynin—Ill-defined disorder—Dactinomycin—melanoma	0.000957	0.00267	CcSEcCtD
Oxybutynin—Liver function test abnormal—Docetaxel—melanoma	0.000951	0.00265	CcSEcCtD
Oxybutynin—Vomiting—Vemurafenib—melanoma	0.000947	0.00264	CcSEcCtD
Oxybutynin—Dry skin—Docetaxel—melanoma	0.000944	0.00264	CcSEcCtD
Oxybutynin—Chest pain—Bleomycin—melanoma	0.000941	0.00263	CcSEcCtD
Oxybutynin—Abdominal pain upper—Docetaxel—melanoma	0.000941	0.00263	CcSEcCtD
Oxybutynin—Rash—Vemurafenib—melanoma	0.000939	0.00262	CcSEcCtD
Oxybutynin—Mental disorder—Temozolomide—melanoma	0.000939	0.00262	CcSEcCtD
Oxybutynin—Dermatitis—Vemurafenib—melanoma	0.000938	0.00262	CcSEcCtD
Oxybutynin—Back pain—Carmustine—melanoma	0.000934	0.00261	CcSEcCtD
Oxybutynin—Headache—Vemurafenib—melanoma	0.000933	0.00261	CcSEcCtD
Oxybutynin—Erythema—Temozolomide—melanoma	0.000933	0.0026	CcSEcCtD
Oxybutynin—Malnutrition—Temozolomide—melanoma	0.000933	0.0026	CcSEcCtD
Oxybutynin—Breast disorder—Docetaxel—melanoma	0.000931	0.0026	CcSEcCtD
Oxybutynin—Discomfort—Bleomycin—melanoma	0.00093	0.0026	CcSEcCtD
Oxybutynin—Malaise—Dactinomycin—melanoma	0.00093	0.0026	CcSEcCtD
Oxybutynin—Nasopharyngitis—Docetaxel—melanoma	0.000921	0.00257	CcSEcCtD
Oxybutynin—Dysgeusia—Temozolomide—melanoma	0.000913	0.00255	CcSEcCtD
Oxybutynin—Confusional state—Bleomycin—melanoma	0.00091	0.00254	CcSEcCtD
Oxybutynin—Vision blurred—Carmustine—melanoma	0.00091	0.00254	CcSEcCtD
Oxybutynin—Oedema—Bleomycin—melanoma	0.000902	0.00252	CcSEcCtD
Oxybutynin—Anaphylactic shock—Bleomycin—melanoma	0.000902	0.00252	CcSEcCtD
Oxybutynin—Back pain—Temozolomide—melanoma	0.000902	0.00252	CcSEcCtD
Oxybutynin—Infection—Bleomycin—melanoma	0.000897	0.0025	CcSEcCtD
Oxybutynin—Dysphagia—Docetaxel—melanoma	0.00089	0.00249	CcSEcCtD
Oxybutynin—Agitation—Carmustine—melanoma	0.000887	0.00248	CcSEcCtD
Oxybutynin—Nausea—Vemurafenib—melanoma	0.000885	0.00247	CcSEcCtD
Oxybutynin—Vision blurred—Temozolomide—melanoma	0.000879	0.00245	CcSEcCtD
Oxybutynin—Discomfort—Dactinomycin—melanoma	0.000867	0.00242	CcSEcCtD
Oxybutynin—Ill-defined disorder—Temozolomide—melanoma	0.000865	0.00242	CcSEcCtD
Oxybutynin—Anorexia—Bleomycin—melanoma	0.00086	0.0024	CcSEcCtD
Oxybutynin—Agitation—Temozolomide—melanoma	0.000857	0.00239	CcSEcCtD
Oxybutynin—Angioedema—Temozolomide—melanoma	0.000852	0.00238	CcSEcCtD
Oxybutynin—Hypotension—Bleomycin—melanoma	0.000843	0.00235	CcSEcCtD
Oxybutynin—Oedema—Dactinomycin—melanoma	0.000842	0.00235	CcSEcCtD
Oxybutynin—Malaise—Temozolomide—melanoma	0.000841	0.00235	CcSEcCtD
Oxybutynin—Convulsion—Carmustine—melanoma	0.000836	0.00233	CcSEcCtD
Oxybutynin—Infection—Dactinomycin—melanoma	0.000836	0.00233	CcSEcCtD
Oxybutynin—Hypertension—Carmustine—melanoma	0.000833	0.00233	CcSEcCtD
Oxybutynin—Palpitations—Temozolomide—melanoma	0.000824	0.0023	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000822	0.0023	CcSEcCtD
Oxybutynin—Chest pain—Carmustine—melanoma	0.000822	0.00229	CcSEcCtD
Oxybutynin—Anxiety—Carmustine—melanoma	0.000819	0.00229	CcSEcCtD
Oxybutynin—Cough—Temozolomide—melanoma	0.000814	0.00227	CcSEcCtD
Oxybutynin—Paraesthesia—Bleomycin—melanoma	0.00081	0.00226	CcSEcCtD
Oxybutynin—Convulsion—Temozolomide—melanoma	0.000808	0.00226	CcSEcCtD
Oxybutynin—Hypertension—Temozolomide—melanoma	0.000805	0.00225	CcSEcCtD
Oxybutynin—Anorexia—Dactinomycin—melanoma	0.000802	0.00224	CcSEcCtD
Oxybutynin—Confusional state—Carmustine—melanoma	0.000794	0.00222	CcSEcCtD
Oxybutynin—Arthralgia—Temozolomide—melanoma	0.000794	0.00222	CcSEcCtD
Oxybutynin—Infestation NOS—Docetaxel—melanoma	0.000794	0.00222	CcSEcCtD
Oxybutynin—Infestation—Docetaxel—melanoma	0.000794	0.00222	CcSEcCtD
Oxybutynin—Anxiety—Temozolomide—melanoma	0.000791	0.00221	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000789	0.0022	CcSEcCtD
Oxybutynin—Oedema—Carmustine—melanoma	0.000788	0.0022	CcSEcCtD
Oxybutynin—Discomfort—Temozolomide—melanoma	0.000785	0.00219	CcSEcCtD
Oxybutynin—Decreased appetite—Bleomycin—melanoma	0.000784	0.00219	CcSEcCtD
Oxybutynin—Infection—Carmustine—melanoma	0.000783	0.00218	CcSEcCtD
Oxybutynin—Dry mouth—Temozolomide—melanoma	0.000777	0.00217	CcSEcCtD
Oxybutynin—Stomatitis—Docetaxel—melanoma	0.000774	0.00216	CcSEcCtD
Oxybutynin—Pain—Bleomycin—melanoma	0.000772	0.00215	CcSEcCtD
Oxybutynin—Conjunctivitis—Docetaxel—melanoma	0.000772	0.00215	CcSEcCtD
Oxybutynin—Tachycardia—Carmustine—melanoma	0.000769	0.00215	CcSEcCtD
Oxybutynin—Confusional state—Temozolomide—melanoma	0.000768	0.00214	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000767	0.00214	CcSEcCtD
Oxybutynin—Anaphylactic shock—Temozolomide—melanoma	0.000761	0.00213	CcSEcCtD
Oxybutynin—Oedema—Temozolomide—melanoma	0.000761	0.00213	CcSEcCtD
Oxybutynin—Infection—Temozolomide—melanoma	0.000756	0.00211	CcSEcCtD
Oxybutynin—Anorexia—Carmustine—melanoma	0.000751	0.0021	CcSEcCtD
Oxybutynin—Epistaxis—Docetaxel—melanoma	0.000749	0.00209	CcSEcCtD
Oxybutynin—Nervous system disorder—Temozolomide—melanoma	0.000747	0.00208	CcSEcCtD
Oxybutynin—Feeling abnormal—Bleomycin—melanoma	0.000744	0.00208	CcSEcCtD
Oxybutynin—Skin disorder—Temozolomide—melanoma	0.000739	0.00206	CcSEcCtD
Oxybutynin—Hypotension—Carmustine—melanoma	0.000736	0.00206	CcSEcCtD
Oxybutynin—Decreased appetite—Dactinomycin—melanoma	0.000732	0.00204	CcSEcCtD
Oxybutynin—Fatigue—Dactinomycin—melanoma	0.000726	0.00203	CcSEcCtD
Oxybutynin—Anorexia—Temozolomide—melanoma	0.000726	0.00203	CcSEcCtD
Oxybutynin—Pain—Dactinomycin—melanoma	0.00072	0.00201	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Carmustine—melanoma	0.000718	0.002	CcSEcCtD
Oxybutynin—Urticaria—Bleomycin—melanoma	0.000717	0.002	CcSEcCtD
Oxybutynin—Rhinitis—Docetaxel—melanoma	0.000714	0.00199	CcSEcCtD
Oxybutynin—Insomnia—Carmustine—melanoma	0.000712	0.00199	CcSEcCtD
Oxybutynin—Hypoaesthesia—Docetaxel—melanoma	0.000709	0.00198	CcSEcCtD
Oxybutynin—Paraesthesia—Carmustine—melanoma	0.000707	0.00197	CcSEcCtD
Oxybutynin—Pharyngitis—Docetaxel—melanoma	0.000707	0.00197	CcSEcCtD
Oxybutynin—Urinary tract disorder—Docetaxel—melanoma	0.000704	0.00196	CcSEcCtD
Oxybutynin—Oedema peripheral—Docetaxel—melanoma	0.000702	0.00196	CcSEcCtD
Oxybutynin—Somnolence—Carmustine—melanoma	0.0007	0.00196	CcSEcCtD
Oxybutynin—Connective tissue disorder—Docetaxel—melanoma	0.0007	0.00195	CcSEcCtD
Oxybutynin—Urethral disorder—Docetaxel—melanoma	0.000698	0.00195	CcSEcCtD
Oxybutynin—Feeling abnormal—Dactinomycin—melanoma	0.000694	0.00194	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000694	0.00194	CcSEcCtD
Oxybutynin—Insomnia—Temozolomide—melanoma	0.000688	0.00192	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Dactinomycin—melanoma	0.000688	0.00192	CcSEcCtD
Oxybutynin—Visual impairment—Docetaxel—melanoma	0.000687	0.00192	CcSEcCtD
Oxybutynin—Decreased appetite—Carmustine—melanoma	0.000685	0.00191	CcSEcCtD
Oxybutynin—Paraesthesia—Temozolomide—melanoma	0.000684	0.00191	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Carmustine—melanoma	0.00068	0.0019	CcSEcCtD
Oxybutynin—Somnolence—Temozolomide—melanoma	0.000677	0.00189	CcSEcCtD
Oxybutynin—Pain—Carmustine—melanoma	0.000674	0.00188	CcSEcCtD
Oxybutynin—Constipation—Carmustine—melanoma	0.000674	0.00188	CcSEcCtD
Oxybutynin—Dyspepsia—Temozolomide—melanoma	0.00067	0.00187	CcSEcCtD
Oxybutynin—Eye disorder—Docetaxel—melanoma	0.000666	0.00186	CcSEcCtD
Oxybutynin—Abdominal pain—Dactinomycin—melanoma	0.000665	0.00186	CcSEcCtD
Oxybutynin—Hypersensitivity—Bleomycin—melanoma	0.000665	0.00186	CcSEcCtD
Oxybutynin—Decreased appetite—Temozolomide—melanoma	0.000662	0.00185	CcSEcCtD
Oxybutynin—Flushing—Docetaxel—melanoma	0.000661	0.00185	CcSEcCtD
Oxybutynin—Cardiac disorder—Docetaxel—melanoma	0.000661	0.00185	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Temozolomide—melanoma	0.000657	0.00183	CcSEcCtD
Oxybutynin—Fatigue—Temozolomide—melanoma	0.000656	0.00183	CcSEcCtD
Oxybutynin—Constipation—Temozolomide—melanoma	0.000651	0.00182	CcSEcCtD
Oxybutynin—Pain—Temozolomide—melanoma	0.000651	0.00182	CcSEcCtD
Oxybutynin—Feeling abnormal—Carmustine—melanoma	0.000649	0.00181	CcSEcCtD
Oxybutynin—Asthenia—Bleomycin—melanoma	0.000647	0.00181	CcSEcCtD
Oxybutynin—Angiopathy—Docetaxel—melanoma	0.000646	0.0018	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Carmustine—melanoma	0.000644	0.0018	CcSEcCtD
Oxybutynin—Mediastinal disorder—Docetaxel—melanoma	0.000642	0.00179	CcSEcCtD
Oxybutynin—Pruritus—Bleomycin—melanoma	0.000638	0.00178	CcSEcCtD
Oxybutynin—Arrhythmia—Docetaxel—melanoma	0.000637	0.00178	CcSEcCtD
Oxybutynin—Feeling abnormal—Temozolomide—melanoma	0.000627	0.00175	CcSEcCtD
Oxybutynin—Mental disorder—Docetaxel—melanoma	0.000624	0.00174	CcSEcCtD
Oxybutynin—Abdominal pain—Carmustine—melanoma	0.000623	0.00174	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Temozolomide—melanoma	0.000622	0.00174	CcSEcCtD
Oxybutynin—Erythema—Docetaxel—melanoma	0.00062	0.00173	CcSEcCtD
Oxybutynin—Malnutrition—Docetaxel—melanoma	0.00062	0.00173	CcSEcCtD
Oxybutynin—Hypersensitivity—Dactinomycin—melanoma	0.00062	0.00173	CcSEcCtD
Oxybutynin—Dysgeusia—Docetaxel—melanoma	0.000607	0.0017	CcSEcCtD
Oxybutynin—Urticaria—Temozolomide—melanoma	0.000605	0.00169	CcSEcCtD
Oxybutynin—Asthenia—Dactinomycin—melanoma	0.000604	0.00169	CcSEcCtD
Oxybutynin—Abdominal pain—Temozolomide—melanoma	0.000602	0.00168	CcSEcCtD
Oxybutynin—Back pain—Docetaxel—melanoma	0.0006	0.00168	CcSEcCtD
Oxybutynin—Hypersensitivity—Carmustine—melanoma	0.00058	0.00162	CcSEcCtD
Oxybutynin—Diarrhoea—Dactinomycin—melanoma	0.000576	0.00161	CcSEcCtD
Oxybutynin—Vomiting—Bleomycin—melanoma	0.000574	0.0016	CcSEcCtD
Oxybutynin—Rash—Bleomycin—melanoma	0.000569	0.00159	CcSEcCtD
Oxybutynin—Dermatitis—Bleomycin—melanoma	0.000568	0.00159	CcSEcCtD
Oxybutynin—Asthenia—Carmustine—melanoma	0.000565	0.00158	CcSEcCtD
Oxybutynin—Hypersensitivity—Temozolomide—melanoma	0.000561	0.00157	CcSEcCtD
Oxybutynin—Syncope—Docetaxel—melanoma	0.000556	0.00155	CcSEcCtD
Oxybutynin—Palpitations—Docetaxel—melanoma	0.000548	0.00153	CcSEcCtD
Oxybutynin—Asthenia—Temozolomide—melanoma	0.000546	0.00152	CcSEcCtD
Oxybutynin—Loss of consciousness—Docetaxel—melanoma	0.000545	0.00152	CcSEcCtD
Oxybutynin—Cough—Docetaxel—melanoma	0.000541	0.00151	CcSEcCtD
Oxybutynin—Diarrhoea—Carmustine—melanoma	0.000539	0.0015	CcSEcCtD
Oxybutynin—Pruritus—Temozolomide—melanoma	0.000539	0.0015	CcSEcCtD
Oxybutynin—Convulsion—Docetaxel—melanoma	0.000537	0.0015	CcSEcCtD
Oxybutynin—Nausea—Bleomycin—melanoma	0.000536	0.0015	CcSEcCtD
Oxybutynin—Hypertension—Docetaxel—melanoma	0.000536	0.0015	CcSEcCtD
Oxybutynin—Vomiting—Dactinomycin—melanoma	0.000535	0.00149	CcSEcCtD
Oxybutynin—Rash—Dactinomycin—melanoma	0.000531	0.00148	CcSEcCtD
Oxybutynin—Arthralgia—Docetaxel—melanoma	0.000528	0.00147	CcSEcCtD
Oxybutynin—Chest pain—Docetaxel—melanoma	0.000528	0.00147	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000524	0.00146	CcSEcCtD
Oxybutynin—Dizziness—Carmustine—melanoma	0.000521	0.00145	CcSEcCtD
Oxybutynin—Diarrhoea—Temozolomide—melanoma	0.000521	0.00145	CcSEcCtD
Oxybutynin—Dry mouth—Docetaxel—melanoma	0.000516	0.00144	CcSEcCtD
Oxybutynin—Confusional state—Docetaxel—melanoma	0.00051	0.00143	CcSEcCtD
Oxybutynin—Oedema—Docetaxel—melanoma	0.000506	0.00141	CcSEcCtD
Oxybutynin—Anaphylactic shock—Docetaxel—melanoma	0.000506	0.00141	CcSEcCtD
Oxybutynin—Dizziness—Temozolomide—melanoma	0.000503	0.00141	CcSEcCtD
Oxybutynin—Infection—Docetaxel—melanoma	0.000503	0.0014	CcSEcCtD
Oxybutynin—Vomiting—Carmustine—melanoma	0.000501	0.0014	CcSEcCtD
Oxybutynin—Nausea—Dactinomycin—melanoma	0.0005	0.0014	CcSEcCtD
Oxybutynin—Shock—Docetaxel—melanoma	0.000498	0.00139	CcSEcCtD
Oxybutynin—Rash—Carmustine—melanoma	0.000497	0.00139	CcSEcCtD
Oxybutynin—Nervous system disorder—Docetaxel—melanoma	0.000496	0.00139	CcSEcCtD
Oxybutynin—Dermatitis—Carmustine—melanoma	0.000496	0.00139	CcSEcCtD
Oxybutynin—Tachycardia—Docetaxel—melanoma	0.000494	0.00138	CcSEcCtD
Oxybutynin—Headache—Carmustine—melanoma	0.000493	0.00138	CcSEcCtD
Oxybutynin—Skin disorder—Docetaxel—melanoma	0.000492	0.00137	CcSEcCtD
Oxybutynin—Vomiting—Temozolomide—melanoma	0.000484	0.00135	CcSEcCtD
Oxybutynin—Anorexia—Docetaxel—melanoma	0.000483	0.00135	CcSEcCtD
Oxybutynin—Rash—Temozolomide—melanoma	0.00048	0.00134	CcSEcCtD
Oxybutynin—Dermatitis—Temozolomide—melanoma	0.00048	0.00134	CcSEcCtD
Oxybutynin—Headache—Temozolomide—melanoma	0.000477	0.00133	CcSEcCtD
Oxybutynin—Hypotension—Docetaxel—melanoma	0.000473	0.00132	CcSEcCtD
Oxybutynin—Nausea—Carmustine—melanoma	0.000468	0.00131	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000461	0.00129	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—melanoma	0.000458	0.00128	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—melanoma	0.000455	0.00127	CcSEcCtD
Oxybutynin—Nausea—Temozolomide—melanoma	0.000452	0.00126	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—melanoma	0.00045	0.00126	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—melanoma	0.000446	0.00124	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—melanoma	0.00044	0.00123	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—melanoma	0.000437	0.00122	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—melanoma	0.000436	0.00122	CcSEcCtD
Oxybutynin—Pain—Docetaxel—melanoma	0.000433	0.00121	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—melanoma	0.000433	0.00121	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—melanoma	0.000417	0.00116	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—melanoma	0.000414	0.00116	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—melanoma	0.0004	0.00112	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—melanoma	0.000373	0.00104	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—melanoma	0.000363	0.00101	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—melanoma	0.000358	0.001	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—melanoma	0.000346	0.000967	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—melanoma	0.000335	0.000935	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—melanoma	0.000322	0.000899	CcSEcCtD
Oxybutynin—Rash—Docetaxel—melanoma	0.000319	0.000891	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—melanoma	0.000319	0.00089	CcSEcCtD
Oxybutynin—Headache—Docetaxel—melanoma	0.000317	0.000885	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—melanoma	0.000301	0.00084	CcSEcCtD
Oxybutynin—CHRM3—Signaling Pathways—TERT—melanoma	2.14e-05	0.000131	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAC1—melanoma	2.14e-05	0.000131	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL2—melanoma	2.13e-05	0.00013	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TERT—melanoma	2.12e-05	0.00013	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAC1—melanoma	2.12e-05	0.00013	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—melanoma	2.09e-05	0.000128	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—melanoma	2.06e-05	0.000126	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—melanoma	2.05e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—melanoma	2.04e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—melanoma	2.03e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MDM2—melanoma	2.03e-05	0.000124	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PRKCA—melanoma	2.01e-05	0.000123	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—VCAN—melanoma	2e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB2—melanoma	2e-05	0.000122	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ERCC2—melanoma	1.99e-05	0.000122	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CB—melanoma	1.97e-05	0.000121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—melanoma	1.97e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—melanoma	1.96e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—melanoma	1.94e-05	0.000119	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CD—melanoma	1.9e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—melanoma	1.9e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FN1—melanoma	1.89e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FN1—melanoma	1.89e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HRAS—melanoma	1.88e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—melanoma	1.88e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FN1—melanoma	1.87e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH1—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1B—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH1—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—melanoma	1.83e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH1—melanoma	1.83e-05	0.000112	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—melanoma	1.82e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CD80—melanoma	1.82e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KIT—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APC—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—NRAS—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CD80—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KIT—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APC—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—NRAS—melanoma	1.81e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—melanoma	1.8e-05	0.00011	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CD80—melanoma	1.79e-05	0.00011	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—melanoma	1.79e-05	0.00011	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGF—melanoma	1.79e-05	0.00011	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KIT—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—NRAS—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGF—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGF—melanoma	1.77e-05	0.000108	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—melanoma	1.77e-05	0.000108	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—melanoma	1.75e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CTNNB1—melanoma	1.75e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK3—melanoma	1.74e-05	0.000106	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK3—melanoma	1.73e-05	0.000106	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—melanoma	1.71e-05	0.000105	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK3—melanoma	1.71e-05	0.000105	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—melanoma	1.71e-05	0.000105	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NFKB1—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP17A1—melanoma	1.69e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—melanoma	1.68e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—melanoma	1.66e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1—melanoma	1.66e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—melanoma	1.66e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK1—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PRKCA—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK1—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—melanoma	1.65e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—melanoma	1.64e-05	0.0001	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1—melanoma	1.64e-05	0.0001	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ERCC2—melanoma	1.64e-05	0.0001	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.63e-05	9.97e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—melanoma	1.63e-05	9.97e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAP2K1—melanoma	1.6e-05	9.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.6e-05	9.78e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—melanoma	1.6e-05	9.77e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GNA11—melanoma	1.6e-05	9.77e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—melanoma	1.59e-05	9.75e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.59e-05	9.72e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.58e-05	9.69e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	1.58e-05	9.65e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—melanoma	1.58e-05	9.65e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—melanoma	1.57e-05	9.63e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.57e-05	9.62e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.57e-05	9.62e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—FASN—melanoma	1.56e-05	9.56e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—melanoma	1.56e-05	9.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.56e-05	9.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—melanoma	1.56e-05	9.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—melanoma	1.54e-05	9.42e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—melanoma	1.54e-05	9.42e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC5A5—melanoma	1.54e-05	9.4e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGF2—melanoma	1.53e-05	9.33e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—melanoma	1.52e-05	9.33e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGF2—melanoma	1.52e-05	9.3e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NRAS—melanoma	1.52e-05	9.3e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—melanoma	1.52e-05	9.29e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGF2—melanoma	1.51e-05	9.21e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GNAQ—melanoma	1.48e-05	9.08e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CD44—melanoma	1.48e-05	9.08e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK3—melanoma	1.46e-05	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.43e-05	8.77e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—melanoma	1.43e-05	8.75e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.43e-05	8.74e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MDM2—melanoma	1.43e-05	8.73e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1B1—melanoma	1.42e-05	8.7e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MDM2—melanoma	1.42e-05	8.7e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—melanoma	1.42e-05	8.67e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—melanoma	1.41e-05	8.65e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MDM2—melanoma	1.41e-05	8.62e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—melanoma	1.41e-05	8.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—melanoma	1.4e-05	8.58e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—melanoma	1.39e-05	8.52e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—melanoma	1.39e-05	8.5e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.39e-05	8.5e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK1—melanoma	1.39e-05	8.48e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—melanoma	1.39e-05	8.48e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.38e-05	8.47e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—melanoma	1.38e-05	8.46e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—melanoma	1.38e-05	8.44e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—melanoma	1.37e-05	8.39e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—melanoma	1.37e-05	8.35e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—melanoma	1.33e-05	8.16e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—melanoma	1.33e-05	8.14e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—melanoma	1.33e-05	8.11e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—melanoma	1.32e-05	8.09e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—melanoma	1.32e-05	8.06e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—melanoma	1.31e-05	8.01e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—melanoma	1.31e-05	8.01e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.3e-05	7.97e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.3e-05	7.95e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—melanoma	1.29e-05	7.9e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.29e-05	7.89e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1B—melanoma	1.29e-05	7.87e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.29e-05	7.86e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—melanoma	1.28e-05	7.81e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—melanoma	1.28e-05	7.8e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—melanoma	1.27e-05	7.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—melanoma	1.27e-05	7.79e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—melanoma	1.27e-05	7.78e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—melanoma	1.27e-05	7.76e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—melanoma	1.27e-05	7.74e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—melanoma	1.26e-05	7.71e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—melanoma	1.26e-05	7.7e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—melanoma	1.25e-05	7.66e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—melanoma	1.25e-05	7.63e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—melanoma	1.24e-05	7.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—melanoma	1.24e-05	7.58e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNB1—melanoma	1.23e-05	7.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNB1—melanoma	1.23e-05	7.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—melanoma	1.23e-05	7.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNB1—melanoma	1.22e-05	7.44e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—melanoma	1.21e-05	7.38e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—melanoma	1.21e-05	7.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—melanoma	1.2e-05	7.36e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—melanoma	1.2e-05	7.36e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—melanoma	1.2e-05	7.36e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—melanoma	1.2e-05	7.36e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—melanoma	1.2e-05	7.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—melanoma	1.2e-05	7.33e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—melanoma	1.2e-05	7.32e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—melanoma	1.19e-05	7.31e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NFKB1—melanoma	1.19e-05	7.31e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—melanoma	1.19e-05	7.29e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NFKB1—melanoma	1.19e-05	7.28e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.19e-05	7.26e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—melanoma	1.18e-05	7.25e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NFKB1—melanoma	1.18e-05	7.21e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—melanoma	1.17e-05	7.17e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—melanoma	1.17e-05	7.16e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—melanoma	1.17e-05	7.14e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—melanoma	1.16e-05	7.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—melanoma	1.16e-05	7.07e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—melanoma	1.14e-05	6.95e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—melanoma	1.12e-05	6.86e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—melanoma	1.11e-05	6.81e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—melanoma	1.08e-05	6.63e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—melanoma	1.08e-05	6.61e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PRKCA—melanoma	1.08e-05	6.6e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—melanoma	1.07e-05	6.57e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NRAS—melanoma	1.07e-05	6.55e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—melanoma	1.07e-05	6.55e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—melanoma	1.07e-05	6.55e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ERCC2—melanoma	1.07e-05	6.54e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NRAS—melanoma	1.07e-05	6.53e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—melanoma	1.06e-05	6.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—melanoma	1.06e-05	6.48e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NRAS—melanoma	1.06e-05	6.47e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—melanoma	1.04e-05	6.37e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK3—melanoma	1.03e-05	6.27e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK3—melanoma	1.02e-05	6.25e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK3—melanoma	1.01e-05	6.19e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—melanoma	1.01e-05	6.17e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—melanoma	9.97e-06	6.1e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—melanoma	9.94e-06	6.08e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—melanoma	9.9e-06	6.06e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—melanoma	9.85e-06	6.02e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—melanoma	9.82e-06	6.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—melanoma	9.81e-06	6e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK1—melanoma	9.76e-06	5.97e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—melanoma	9.76e-06	5.97e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK1—melanoma	9.73e-06	5.95e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—melanoma	9.72e-06	5.95e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK1—melanoma	9.63e-06	5.89e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—melanoma	9.63e-06	5.89e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—melanoma	9.22e-06	5.64e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—melanoma	9.19e-06	5.62e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—melanoma	9.1e-06	5.56e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—melanoma	8.55e-06	5.23e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—melanoma	8.49e-06	5.19e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—melanoma	8.47e-06	5.18e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—melanoma	8.45e-06	5.17e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—melanoma	8.44e-06	5.16e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—melanoma	8.36e-06	5.11e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—melanoma	8.25e-06	5.04e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—melanoma	8.19e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—melanoma	8.16e-06	4.99e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—melanoma	8.15e-06	4.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—melanoma	8.09e-06	4.95e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—melanoma	7.83e-06	4.79e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—melanoma	7.81e-06	4.78e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—melanoma	7.73e-06	4.73e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—melanoma	7.5e-06	4.59e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—melanoma	7.47e-06	4.57e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—melanoma	7.43e-06	4.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—melanoma	7.4e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—melanoma	7.35e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—melanoma	7.33e-06	4.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—melanoma	6.93e-06	4.24e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—melanoma	6.92e-06	4.23e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—melanoma	6.89e-06	4.22e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—melanoma	6.83e-06	4.18e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—melanoma	6.47e-06	3.96e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—melanoma	6.41e-06	3.92e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—melanoma	6.03e-06	3.69e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—melanoma	6.01e-06	3.67e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—melanoma	5.59e-06	3.42e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—melanoma	4.93e-06	3.02e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—melanoma	3.95e-06	2.41e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—melanoma	3.22e-06	1.97e-05	CbGpPWpGaD
